The new facility at AIIMS' Neurosciences Centre will monitor the levels of two commonly used anti-epilepsy medicines — levetiracetam and lamotrigine — in a patient's blood. Doctors say this is important because the same dose may affect patients differently, and incorrect drug levels can either fail to control seizures or cause toxicity.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/TdyVeI5
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment